Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho Yan Xing, Michelle J. Smith, Christine A. Goetz, Ron T. McElmurry, Sarah L. Parker, Dullei Min, Georg A. Hollander, Kenneth I. Weinberg, Jakub Tolar, Heather E. Stefanski and Bruce R. Blazar J Immunol December 1, 2018, 201 (11) 3320-3328; DOI: https://doi.org/10.4049/jimmunol.1800670
Thymic Epithelial Cell Support of Thymopoiesis Does Not Require Klotho Yan Xing, Michelle J. Smith, Christine A. Goetz, Ron T. McElmurry, Sarah L. Parker, Dullei Min, Georg A. Hollander, Kenneth I. Weinberg, Jakub Tolar, Heather E. Stefanski and Bruce R. Blazar J Immunol October 29, 2018, ji1800670; DOI: https://doi.org/10.4049/jimmunol.1800670
NK cell infusions induce complete remissions in 30–50% of patients with refractory AML when combined with lymphodepleting chemotherapy and IL-2. NK cell therapy is limited by lack of antigen specificity and by IL-2 mediated induction of Tregs. To overcome these limitations we developed a 161533 trispecific killer engager (TriKE) molecule containing an anti-CD16 scFv, to engage NK cells, an anti-CD33 scFv, to engage AML targets, and an IL-15 molecule.
As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.